Jae Park

A Phase 2 Study of Actinium-225 (225Ac)-lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML)

M. Berger, W. Tse, D. Rizzieri, 2019, Journal of Medical Imaging and Radiation Sciences.